| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $992,548 ) |
| | 2024 | 2024 | WHITMAN-WALKER INSTITUTE INC | 1525 14TH ST NW | WASHINGTON | DC | 20005-3706 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 000 | 5 | NIH | 3/1/2024 | $200,000 |
| | 2024 | 2024 | WHITMAN-WALKER INSTITUTE INC | 1525 14TH ST NW | WASHINGTON | DC | 20005-3706 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 000 | 5 | NIH | 3/1/2024 | $792,548 |
| | 2024 | 2022 | WHITMAN-WALKER INSTITUTE INC | 1525 14TH ST NW | WASHINGTON | DC | 20005-3706 | DISTRICT OF COLUMBIA | USA | C06OD034040 | Developing a Community-Based Facility to Support Next Generation Biomedical HIV Research | 000 | 1 | NIH | 1/31/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $209,344 ) |
| | 2023 | 2023 | WHITMAN-WALKER INSTITUTE INC | 1525 14TH ST NW | WASHINGTON | DC | 20005-3706 | DISTRICT OF COLUMBIA | USA | K01MH134764 | Intersectional discrimination and linkage to HIV prevention and care in transgender women in Ecuador | 000 | 1 | NIH | 9/15/2023 | $209,344 |
| | 2023 | 2022 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 000 | 4 | NIH | 3/13/2023 | $0 |
| | 2023 | 2022 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 000 | 4 | NIH | 3/13/2023 | $0 |
| | 2023 | 2022 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | C06OD034040 | Developing a Community-Based Facility to Support Next Generation Biomedical HIV Research | 000 | 1 | NIH | 11/4/2022 | $0 |
| | 2023 | 2021 | WHITMAN-WALKER INSTITUTE INC | 1525 14TH ST NW | WASHINGTON | DC | 20005-3706 | DISTRICT OF COLUMBIA | USA | UH3AI133674 | Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men | 000 | 5 | NIH | 7/11/2023 | $0 |
| | 2023 | 2021 | WHITMAN-WALKER INSTITUTE INC | 1525 14TH ST NW | WASHINGTON | DC | 20005-3706 | DISTRICT OF COLUMBIA | USA | UH3AI133674 | Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men | 000 | 5 | NIH | 7/11/2023 | $0 |
| | 2023 | 2021 | WHITMAN-WALKER INSTITUTE INC | 1525 14TH ST NW | WASHINGTON | DC | 20005-3706 | DISTRICT OF COLUMBIA | USA | UH3AI133674 | Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men | 000 | 5 | NIH | 7/11/2023 | $0 |
| | 2023 | 2021 | WHITMAN-WALKER INSTITUTE INC | 1525 14TH ST NW | WASHINGTON | DC | 20005-3706 | DISTRICT OF COLUMBIA | USA | R01MH114735 | Testing a Biopsychosocial Model of Minority Stress and Health for HIV-Positive Men | 000 | 5 | NIH | 7/12/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $4,474,942 ) |
| | 2022 | 2022 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 005 | 4 | NIH | 3/7/2022 | -$262,245 |
| | 2022 | 2022 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 001 | 4 | NIH | 3/1/2022 | $200,000 |
| | 2022 | 2022 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 001 | 4 | NIH | 3/1/2022 | $915,927 |
| | 2022 | 2022 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 004 | 4 | NIH | 3/7/2022 | $262,245 |
| | 2022 | 2022 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | C06OD034040 | Developing a Community-Based Facility to Support Next Generation Biomedical HIV Research | 000 | 1 | NIH | 9/16/2022 | $2,000,000 |
| | 2022 | 2022 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 004 | 4 | NIH | 3/7/2022 | $31,146 |
| | 2022 | 2022 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 005 | 4 | NIH | 3/7/2022 | -$31,146 |
| | 2022 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01MH114735 | Testing a Biopsychosocial Model of Minority Stress and Health for HIV-Positive Men | 001 | 5 | NIH | 12/21/2021 | $690,093 |
| | 2022 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01MH114735 | Testing a Biopsychosocial Model of Minority Stress and Health for HIV-Positive Men | 002 | 5 | NIH | 3/2/2022 | $5,233 |
| | 2022 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | UH3AI133674 | Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men | 001 | 5 | NIH | 2/14/2022 | $358,194 |
| | 2022 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | UH3AI133674 | Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men | 002 | 5 | NIH | 5/9/2022 | $7,305 |
| | 2022 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | UH3AI133674 | Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men | 003 | 5 | NIH | 7/26/2022 | $0 |
| | 2022 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | UH3AI133674 | Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men | 003 | 5 | NIH | 7/26/2022 | $0 |
| | 2022 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | UH3AI133674 | Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men | 003 | 5 | NIH | 7/26/2022 | $0 |
| | 2022 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 006 | 3 | NIH | 3/7/2022 | $293,391 |
| | 2022 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 000 | 3 | NIH | 2/25/2022 | $4,800 |
| | 2022 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 007 | 3 | NIH | 3/15/2022 | -$31,146 |
| | 2022 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 007 | 3 | NIH | 3/15/2022 | $31,146 |
|
| Issue Date FY: 2021 ( Subtotal = $2,300,583 ) |
| | 2021 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | UH3AI133674 | Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men | 001 | 5 | NIH | 8/5/2021 | $250,000 |
| | 2021 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01MH114735 | Testing a Biopsychosocial Model of Minority Stress and Health for HIV-Positive Men | 001 | 5 | NIH | 7/22/2021 | $650,281 |
| | 2021 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | UH3AI133674 | Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men | 001 | 5 | NIH | 8/5/2021 | $125,000 |
| | 2021 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | UH3AI133674 | Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men | 001 | 5 | NIH | 8/5/2021 | $485,533 |
| | 2021 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 002 | 3 | NIH | 8/18/2021 | $200,000 |
| | 2021 | 2021 | WHITMAN-WALKER INSTITUTE, INC. | 1377 R ST NW STE 200 | WASHINGTON | DC | 20009-6293 | DISTRICT OF COLUMBIA | USA | R01AI150502 | Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | 002 | 3 | NIH | 8/18/2021 | $589,769 |
|
|
